☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
BLOCKSTONE
Roche's Xofluza Receives the EC's Approval for the Treatment of Influenza
January 11, 2021
Roche Reports Positive Results of Xofluza (baloxavir marboxil) in Two P-III MINISTONE-2 and BLOCKSTONE Studies for Influenza Infec...
September 2, 2019
Roche Reports Results of Xofluza (baloxavir marboxil) in P-III BLOCKSTONE Study for the Prevention of Influenza
June 4, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.